Identification of Chromoblastomycosis and Phaeohyphomycosis Agents through ITS-RFLP
-
Published:2024-02-18
Issue:2
Volume:10
Page:159
-
ISSN:2309-608X
-
Container-title:Journal of Fungi
-
language:en
-
Short-container-title:JoF
Author:
Sousa Gabriel S. M.1ORCID, De Oliveira Rodrigo S.2ORCID, De Souza Alex B.2ORCID, Monteiro Ruan C.3, Santo Elaine P. T. E.2, Franco Filho Luciano C.2ORCID, Da Silva Silvia H. M.2ORCID
Affiliation:
1. Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-750, Brazil 2. Laboratório de Micoses Superficiais e Sistêmicas, Seção de Bacteriologia e Micologia, Instituto Evandro Chagas, Ananindeua 67030-000, Brazil 3. Laboratory of Emerging Fungal Pathogens, Universidade Federal de São Paulo, São Paulo 04023-062, Brazil
Abstract
Chromoblastomycosis (CBM) and phaeohyphomycosis (FEO) are infections caused by melanized filamentous fungal agents, primarily found in tropical and subtropical regions. Both infections pose significant challenges for the correct identification of the causative agent due to their morphological similarity, making conventional methods of morphological analysis highly subjective. Therefore, molecular techniques are necessary for the precise determination of these species. In this regard, this study aimed to contribute to a new methodology based on PCR-RFLP for the identification of agents causing CBM and FEO. Sequences from the Internal Transcribed Spacer (ITS) region were used to identify potential restriction enzyme sites in silico, followed by in vitro validation using the selected restriction enzymes. The obtained results were compared with species identification through morphological analyses and sequencing. The results demonstrated that the PCR-RFLP applied in this study accurately identified two major agents of chromoblastomycosis, Fonsecaea pedrosoi and Fonsecaea monophora, as well as Cladophialophora bantiana and Exophiala dermatitidis, both causative agents of phaeohyphomycosis. In this context, the proposed assay can complement current methods for identifying these species, aiding in diagnosis, and contributing to the proper management of these infections.
Funder
Institute Evandro Chagas (IEC), Department of Health Surveillance, Ministry of Health Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil
Reference42 articles.
1. Phaeohyphomycosis;Arcobello;Semin. Respir. Crit. Care Med.,2020 2. Chromoblastomycosis;Santos;Clin. Microbiol. Rev.,2017 3. Santos, D.W.C.L., Azevedo, C.d.M.P.e.S.d., Vicente, V.A., Queiroz-Telles, F., Rodrigues, A.M., de Hoog, G.S., Denning, D.W., and Colombo, A.L. (2021). The Global Burden of Chromoblastomycosis. PLoS Neglected Trop. Dis., 15. 4. Enbiale, W., Bekele, A., Manaye, N., Seife, F., Kebede, Z., Gebremeskel, F., and van Griensven, J. (2023). Subcutaneous Mycoses: Endemic but Neglected among the Neglected Tropical Diseases in Ethiopia. PLoS Neglected Trop. Dis., 17. 5. WHO (2022). Ending the Neglect to Attain the Sustainable Development Goals: A Strategic Framework for Integrated Control and Management of Skin-Related Neglected Tropical Diseases.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|